Barbara S.
- Country
- Poland
- Department
- Klinika Neurologii Wieku Rozwojowego
Research Overview
- A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Clemizole Hydrochloride as Adjunctive Therapy in Patients with Lennox-Gastaut Syndrome
- Pharmacokinetic, Safety, Tolerability, Immunogenicity and Pharmacodynamic Evaluation of Subcutaneous Ocrelizumab in Pediatric Relapsing‑Remitting Multiple Sclerosis
- Evaluation of Radiprodil's Safety, Tolerability, and Pharmacokinetics in Tuberous Sclerosis Complex and Focal Cortical Dysplasia Type II Patients
Data & Insights
Has run more than one trial at 72 of 157 partner sites.
Specializations
Neurological Disorders
This investigator specializes in treating Multiple Sclerosis (MS), with particular focus on pediatric and adolescent populations. Their research encompasses various therapeutic approaches including ocrelizumab, fingolimod, ofatumumab, and ozanimod treatments.
- Relapsing-Remitting Multiple Sclerosis (RRMS)
- Pediatric MS Management
- Comparative Treatment Studies
Neuromuscular Conditions
The investigator conducts research in Spinal Muscular Atrophy (SMA) and Duchenne Muscular Dystrophy (DMD). Their work includes evaluation of novel treatments such as apitegromab, satralizumab, and combination therapies.
- Type 2 and 3 SMA
- Muscular Dystrophy
- Bone Mineral Density Studies
Epilepsy and Related Disorders
Expertise extends to rare epileptic conditions including Lennox-Gastaut Syndrome, Dravet Syndrome, and Tuberous Sclerosis Complex. Research focuses on innovative treatments such as soticlestat and carisbamate.
- Developmental Epileptic Encephalopathies
- Seizure Management
- Pediatric Neurological Disorders
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.